Alemtuzumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia
Clinical trial NCT00634881 · COMPLETED
Trial details
- NCT number
- NCT00634881
- Sponsor
- German CLL Study Group
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-11-01
- Primary completion
- 2010-01-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.